ABT vs MDT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ABT · Abbott Laboratories$109.93 ▼ 3.23%
MDT · Medtronic$101.80 ▼ 2.90%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ABT -11.1%
- MDT +12.6%
Head to head
| Metric | ABT | MDT |
|---|---|---|
| Price | $109.93 | $101.80 |
| Change today | ▼ 3.23% | ▼ 2.90% |
| Market cap | $190.39B | $130.22B |
| Return, 3 months | +1.2% | +13.9% |
| Return, year to date | -10.6% | +7.8% |
| Return, 1 year | -11.4% | +13.1% |
| P/E (TTM) | 40.9 | 25.1 |
| P/B | 3.7 | 2.6 |
| P/E percentile vs own 5y | 100th | 16th |
| Dividend yield | 2.26% | 2.80% |
| Revenue growth (YoY, latest qtr) | +14.5% | +13.7% |
| Net profit growth (YoY) | -44.0% | +41.3% |
| Gross margin | 56.9% | 65.0% |
| Operating margin | 13.8% | 19.0% |
| Net margin | 9.7% | 13.9% |
| Return on equity | – | 10.7% |
| Analyst target vs. price | +11.3% | +2.6% |
| Analyst buy share | 94% | 56% |
| RSI (14) | 59 | 64 |
| 30-day volatility | 30.9% | 33.0% |
| Max drawdown, 1 year | -36.1% | -28.9% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ABT is the largest of the group by market value.
- MDT has returned the most over the past year.
- MDT carries the lowest trailing P/E.
- MDT pays the highest dividend yield.
- ABT is growing revenue fastest.
- MDT keeps the most profit per dollar of sales.
- ABT has been the calmest stock over the last 30 days.